<DOC>
	<DOCNO>NCT01277978</DOCNO>
	<brief_summary>The purpose study evaluate immediate effect carbetocin oxytocin maternal hemodynamic parameter ( heart rate blood pressure ) non-invasive setup ( TaskeForce®-Monitor ) primary Caesarean section .</brief_summary>
	<brief_title>Haemodynamic Effects Oxytocin Carbetocin</brief_title>
	<detailed_description>As trend toward childbearing late life , pre-existing maternal cardiovascular problem may become frequent pregnancy delivery . In addition increase number woman congenital acquire cardiac disease may tolerate induced haemodynamic change well healthy patient . Therefore uterotonic drug must safe cardiovascular system . Currently oxytocin used common uterotonic agent obstetrics . The use drug uterotonic reason cause serious haemodynamic side effect show several investigator . Preliminary clinical observation maternal heart rate blood pressure suggest use carbetocin cause less hemodynamic change oxytocin . Primary objective ( ) : To evaluate effect carbetocin maternal hemodynamic parameter ( heart rate , blood pressure , systemic vascular resistance , cardiac output , stroke volume , heart rate variability , blood pressure variability ) non-invasive setup ( TaskeForce®-Monitor ) primary Caesarean section . To compare haemodynamic change carbetocin versus oxytocin . Secondary objective ( ) To evaluate need additional drug method control uterine tone .</detailed_description>
	<mesh_term>Carbetocin</mesh_term>
	<mesh_term>Oxytocin</mesh_term>
	<criteria>Healthy pregnant woman undergo elective caesarean section regional anesthesia Women placenta praevia placental abruption multiple gestation pregnancy relate complication disorder ( i.e . preeclampsia , gestational diabetes ) preexist disease ( e.g . insulindependent diabetes , cardiovascular renal disease , thyroid disease take medication know impact cardiovascular system undergoing caesarean section general anesthesia secondary caesarean section</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>January 2011</verification_date>
	<keyword>Caesarean section</keyword>
	<keyword>Cardiovascular effect</keyword>
	<keyword>Postpartum hemorrhage</keyword>
	<keyword>Carbetocin</keyword>
	<keyword>Oxytocin</keyword>
</DOC>